Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sanofi Winthrop Industrie

< Previous 1 2 Next >
News headline image
Press Release: Sanofi announces extension of Blueprint tender offer
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press release: Availability of the Q2 2025 Aide mémoire
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press release: Sanofi successfully prices €1.5 billion bond issue
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi completes acquisition of DR-0201
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Annual General Meeting of April 30, 2025
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
From Sanofi Winthrop Industrie
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.